Xeris Biopharma Holdings Ratios (2020-2025) | XERS

1Y3Y5Y7Y10YAll
Download Data
Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 70.35%53.55%77.72%62.01%70.89%77.19%71.58%80.99%82.30%81.02%83.98%80.12%83.03%82.95%85.31%83.79%74.95%84.23%85.48%83.37%85.22%
EBT Margin -170.14%-297.98%-224.66%-308.95%-235.16%-237.02%-154.59%-104.81%-74.58%-40.03%-50.71%-53.98%-25.93%-30.70%-45.95%-29.66%-35.13%-8.51%-15.34%-2.70%0.83%
EBIT Margin -146.15%-263.71%-204.27%-289.55%-220.24%-225.26%-131.72%-74.75%-63.18%-45.77%-40.00%-42.04%-10.17%-22.17%-35.05%-17.03%-23.76%2.79%-5.14%6.27%9.05%
EBITDA Margin -171.29%-298.66%-224.86%-309.06%-235.22%-237.04%-152.90%-103.42%-73.39%-38.97%-50.73%-52.33%-25.17%-30.11%-46.73%-31.21%-28.97%-8.52%-15.34%-2.69%0.83%
Operating Margin -146.15%-263.71%-204.27%-289.55%-220.24%-225.26%-131.72%-74.75%-63.18%-45.77%-40.00%-42.04%-10.17%-22.17%-35.05%-17.03%-23.76%2.79%-5.14%6.27%9.05%
Net Margin -170.14%-297.98%-224.66%-308.95%-235.16%-237.02%-152.74%-103.47%-73.44%-39.01%-50.71%-52.20%-25.23%-30.16%-46.71%-31.22%-29.00%-8.51%-15.34%-2.70%0.83%
FCF Margin -151.25%-292.32%-224.81%-204.44%-135.69%-219.31%-81.44%-59.73%-48.63%-78.74%-36.16%-30.24%16.83%-49.96%-21.53%-15.30%3.29%-16.69%0.25%24.78%
Efficiency
Inventory Average 16.18M17.50M17.38M19.00M22.43M26.89M32.79M37.34M38.49M39.86M41.93M44.05M46.65M50.43M59.99M67.37M
Assets Average 217.81M320.99M328.12M310.82M323.77M332.94M325.07M328.28M325.19M329.61M334.17M326.42M322.08M319.26M325.07M352.44M
Equity Average 24.05M46.38M95.84M85.20M64.49M50.11M37.62M21.84M8.75M-1.46M-7.98M-14.23M-23.80M-28.97M-32.37M-27.22M-10.08M
Invested Capital 14.34M120.78M85.25M183.30M234.09M212.01M193.55M232.26M217.67M201.82M194.29M184.15M220.50M211.19M187.90M202.49M194.64M199.32M218.61M
Asset Utilization Ratio 0.230.200.240.320.340.360.410.470.500.520.540.570.630.700.760.76
Leverage & Solvency
Interest Coverage Ratio -5.90-4.21-9.30-14.33-13.53-26.82-8.26-5.49-4.70-3.47-2.14-2.45-0.72-1.40-2.03-1.02-1.650.22-0.420.610.92
Debt to Equity 0.501.224.53-30.97-0.11-0.02-0.53-7.84-6.54-11.33-254.90
Debt Ratio 0.050.050.050.650.000.000.050.720.730.650.59
Equity Ratio 0.21-0.020.310.290.230.180.130.090.040.01-0.02-0.03-0.06-0.09-0.09-0.11-0.060.00
Times Interest Earned -5.90-4.21-9.30-14.33-13.53-26.82-8.26-5.49-4.70-3.47-2.14-2.45-0.72-1.40-2.03-1.02-1.650.22-0.420.610.92
Valuation
Enterprise Value -37.89M-133.79M-92.98M-102.43M-132.15M-111.55M-93.43M-121.97M-95.10M-80.67M-65.97M-72.45M-87.35M-77.57M-69.40M-71.62M-58.44M-59.28M-91.60M
Return Ratios
Return on Sales -1.70%-2.98%-2.25%-3.09%-2.35%-2.37%-1.53%-1.03%-0.73%-0.39%-0.51%-0.52%-0.25%-0.30%-0.47%-0.31%-0.29%-0.09%-0.15%-0.03%0.01%
Return on Capital Employed -0.83%-0.50%-0.46%-0.47%-0.33%-0.26%-0.26%-0.20%-0.19%-0.18%-0.14%-0.19%-0.15%-0.10%-0.04%0.04%
Return on Invested Capital -0.61%-0.54%-0.56%-0.38%-0.29%-0.30%-0.24%-0.23%-0.22%-0.17%-0.22%-0.17%-0.11%-0.05%
Return on Assets -0.56%-0.43%-0.42%-0.43%-0.29%-0.23%-0.22%-0.19%-0.19%-0.20%-0.18%-0.19%-0.17%-0.14%-0.10%-0.04%
Return on Equity -2.65%-1.44%-1.60%-2.05%-1.89%-2.07%-3.27%-7.06%42.68%8.07%4.19%2.65%1.89%1.39%1.18%1.55%